Precision Optics Corp. Files 10-K/A Amendment for Fiscal Year Ended June 30, 2023

TL;DR

<b>Precision Optics Corporation, Inc. has filed an amendment to its 2023 10-K report.</b>

AI Summary

PRECISION OPTICS CORPORATION, INC. (POCI) filed a Amended Annual Report (10-K/A) with the SEC on February 28, 2024. Precision Optics Corporation, Inc. filed an amended 10-K report (Amendment No. 1) for the fiscal year ended June 30, 2023. The filing was submitted on February 28, 2024. The company's principal executive offices are located at 22 East Broadway, Gardner, Massachusetts. Precision Optics Corporation, Inc. is incorporated in Massachusetts and has an IRS number of 042795294. The company's common stock, par value $0.01, is registered under the trading symbol POCI on the Nasdaq exchange.

Why It Matters

For investors and stakeholders tracking PRECISION OPTICS CORPORATION, INC., this filing contains several important signals. This amendment provides updated or corrected information for the fiscal year ending June 30, 2023, which is crucial for investors to have the most accurate financial and operational data. The filing confirms the company's status as a non-seasoned issuer and its compliance with filing requirements for the preceding 12 months, indicating ongoing regulatory adherence.

Risk Assessment

Risk Level: low — PRECISION OPTICS CORPORATION, INC. shows low risk based on this filing. The filing is an amendment to a previous 10-K, suggesting potential corrections or additions to previously reported information, but does not indicate new material risks.

Analyst Insight

Review the specific changes made in Amendment No. 1 to the 10-K filing to understand any updated financial or operational details for Precision Optics Corporation, Inc.

Key Numbers

• 20230630 — Fiscal Year End (Conformed Period of Report)
• 20240228 — Filed As Of Date (Date of filing)
• 001-10647 — SEC File Number (Commission File Number)
• 042795294 — IRS Number (Registrant's IRS Employer Identification Number)

Key Players & Entities

• PRECISION OPTICS CORPORATION, INC. (company) — Filer name
• 0001683168-24-001234 (other) — Accession Number
• 20240228 (date) — Filing Date
• 20230630 (date) — Fiscal Year End
• 22 East Broadway (location) — Business Address
• Gardner (location) — City
• Massachusetts (location) — State of Incorporation
• POCI (ticker) — Trading Symbol

FAQ

Industry Context

Precision Optics Corporation, Inc. operates within the electromedical and electrotherapeutic apparatus industry, as indicated by its SIC code 3845.

Regulatory Implications

The company is subject to the reporting requirements of the Securities Exchange Act of 1934, as evidenced by its filing of a Form 10-K/A.

What Investors Should Do

1. Review the full 10-K/A filing for Precision Optics Corporation, Inc. to identify specific amendments and their implications.
2. Verify the accuracy and completeness of the financial and operational data presented in the amended filing.
3. Monitor future filings for any further updates or disclosures from Precision Optics Corporation, Inc.

Key Dates

• 2023-06-30: Fiscal Year End — The period covered by the 10-K/A filing.
• 2024-02-28: Filing Date — Date the amendment was submitted to the SEC.

Year-Over-Year Comparison

This is an amended filing (10-K/A), indicating that it supplements or corrects information previously provided in an earlier filing for the same period.

Key Financial Figures

• $0.01 — nge on which registered Common stock, $0.01 par value POCI Nasdaq Indicate by
• $28,343,118 b — rant on June 30, 2023 was approximately $28,343,118 based on a total of 4,608,637 shares of t
• $6.15 — June 30, 2023, at the closing price of $6.15 per share, as reported on Nasdaq on Jun

Filing Documents

• poci_i10ka1-063023.htm (10-K/A) — 34KB
• poci_ex3101.htm (EX-31.1) — 11KB
• poci_ex3102.htm (EX-31.2) — 12KB
• 0001683168-24-001234.txt (&nbsp;) — 58KB

CONTROLS AND PROCEDURES

ITEM 9A. CONTROLS AND PROCEDURES. Management's Evaluation of Disclosure Controls and Procedures Our Chief Executive Officer and our Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures, including internal control over financial reporting, were effective as of June 30, 2023, to ensure the information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934, as amended (i) is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are intended to be designed to provide reasonable assurance that such information is accumulated and communicated to our management. Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of June 30, 2023. Changes in Internal Control over Financial Reporting There has been no change in our internal control over financial reporting that occurred during the fiscal year covered by this Annual Report on Form 10-K that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. 1 PART IV

EXHIBITS, FINANCIAL STATEMENT

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES. a. Documents filed as part of this report The following documents are filed as part of this Annual Report on 10-K: 1.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS Reference is made to the Index to Financial Statements filed in

, Item 8 hereof

Part II, Item 8 hereof. 2. FINANCIAL STATEMENT SCHEDULES All financial statement schedules have been omitted as they are not required, not applicable, or the required information is otherwise included. b. Exhibits The exhibits listed below are filed as a part of this Amendment No. 1 to the Original Form 10-K. Exhibit Description 31.1* Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed Herewith. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PRECISION OPTICS CORPORATION, INC. Date: February 28, 2024 By: /s/ Joseph N. Forkey Joseph N. Forkey President and Chief Executive Officer (Principal Executive Officer) 3

View Full Filing

View this 10-K/A filing on SEC EDGAR